Davis-based company raises funds to research alternatives to opioids
March 06, 2019 at 09:23 AM EST
The company has been gradually accruing capital since February 2017, with an ultimate goal of raising $15.75 million.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|